Annual Drug Patent Expirations for ALTRENO Altreno is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Dow Pharm drug ALTRENO appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for ZYRTEC-D+12+HOUR Zyrtec-d 12 Hour is a drug marketed by J And J Consumer Inc and is included in one NDA. It is available from one…
The post New patent expiration for J And drug ZYRTEC-D 12 HOUR appeared first on DrugP…
New patent expiration for J And drug ZYRTEC-D 12 HOUR Read Post »
This chart shows the patent expirations for solution dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Solution dosed drug patent expirations by year appeared first on DrugPatentWa…
Annual Drug Patent Expirations for TRULANCE Trulance is a drug marketed by Salix and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
The post New patent expiration for SALIX drug TRULANCE appeared first on…
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Eisai Inc and is included in two NDAs. It is available from one supplier. There are two patents…
The post New patent for Eisai Inc drug FYCOMPA appeared first on DrugPatentWatch -…
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Norway. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical …
Which pharmaceutical companies have the most SPCs in Norway? Read Post »
TRULANCE (plecanatide) Salix Patent: 7,799,897 Expiration: Jun 9, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Paten…
Drug Patent Expirations for the Week of June 5, 2022 Read Post »
Annual Drug Patent Expirations for ZIMHI Zimhi is a drug marketed by Adamis Pharms Corp and is included in one NDA. The generic ingredient in ZIMHI is naloxone hydrochloride. Additional…
The post New patent for Adamis Pharms drug ZIMHI appeared first o…
Annual Drug Patent Expirations for COPIKTRA Copiktra is a drug marketed by Secura and is included in one NDA. There are four patents protecting this drug. This drug has one…
The post New patent for Secura drug COPIKTRA appeared first on DrugPatentWatch…
Get new actionable insights and updates from BiotechBlog
